![Topical Treatment for Cutaneous Leishmaniasis: Dermato-Pharmacokinetic Lead Optimization of Benzoxaboroles | Antimicrobial Agents and Chemotherapy Topical Treatment for Cutaneous Leishmaniasis: Dermato-Pharmacokinetic Lead Optimization of Benzoxaboroles | Antimicrobial Agents and Chemotherapy](https://journals.asm.org/cms/10.1128/AAC.02419-17/asset/9e28e3b4-b569-4aa9-b87d-6f2cab4272e4/assets/graphic/zac0051871380001.jpeg)
Topical Treatment for Cutaneous Leishmaniasis: Dermato-Pharmacokinetic Lead Optimization of Benzoxaboroles | Antimicrobial Agents and Chemotherapy
![Lymphatic Dissemination in Cutaneous Leishmaniasis Following Local Treatment in: The American Journal of Tropical Medicine and Hygiene Volume 93 Issue 4 (2015) Lymphatic Dissemination in Cutaneous Leishmaniasis Following Local Treatment in: The American Journal of Tropical Medicine and Hygiene Volume 93 Issue 4 (2015)](https://www.ajtmh.org/view/journals/tpmd/93/4/full-770fig2.jpg)
Lymphatic Dissemination in Cutaneous Leishmaniasis Following Local Treatment in: The American Journal of Tropical Medicine and Hygiene Volume 93 Issue 4 (2015)
Diagnosis and Treatment of Leishmaniasis: Clinical Practice Guidelines by the Infectious Diseases Society of America (IDSA) and
![PDF) Nonhealing skin lesions in a sailor and a journalist returning from Iraq | Glenn Wortmann - Academia.edu PDF) Nonhealing skin lesions in a sailor and a journalist returning from Iraq | Glenn Wortmann - Academia.edu](https://0.academia-photos.com/attachment_thumbnails/46703266/mini_magick20190209-13293-11ntcov.png?1549703618)
PDF) Nonhealing skin lesions in a sailor and a journalist returning from Iraq | Glenn Wortmann - Academia.edu
Topical Treatment for Cutaneous Leishmaniasis: Dermato-Pharmacokinetic Lead Optimization of Benzoxaboroles
![Development of a topical liposomal formulation of Amphotericin B for the treatment of cutaneous leishmaniasis - ScienceDirect Development of a topical liposomal formulation of Amphotericin B for the treatment of cutaneous leishmaniasis - ScienceDirect](https://ars.els-cdn.com/content/image/1-s2.0-S2211320719300545-fx1.jpg)
Development of a topical liposomal formulation of Amphotericin B for the treatment of cutaneous leishmaniasis - ScienceDirect
![Leishmania major: In vitro and in vivo anti-leishmanial activity of paromomycin ointment (Leshcutan) combined with the immunomodulator Imiquimod - ScienceDirect Leishmania major: In vitro and in vivo anti-leishmanial activity of paromomycin ointment (Leshcutan) combined with the immunomodulator Imiquimod - ScienceDirect](https://ars.els-cdn.com/content/image/1-s2.0-S0014489406003262-gr4.jpg)
Leishmania major: In vitro and in vivo anti-leishmanial activity of paromomycin ointment (Leshcutan) combined with the immunomodulator Imiquimod - ScienceDirect
The lack of effectiveness of hyperbaric oxygenation as a treatment for Leishmania major in a mouse model
Diagnosis and Treatment of Leishmaniasis: Clinical Practice Guidelines by the Infectious Diseases Society of America (IDSA) and
Diagnosis and Treatment of Leishmaniasis: Clinical Practice Guidelines by the Infectious Diseases Society of America (IDSA) and
![Pharmaceutics | Free Full-Text | Film-Forming Systems for the Delivery of DNDI-0690 to Treat Cutaneous Leishmaniasis | HTML Pharmaceutics | Free Full-Text | Film-Forming Systems for the Delivery of DNDI-0690 to Treat Cutaneous Leishmaniasis | HTML](https://www.mdpi.com/pharmaceutics/pharmaceutics-13-00516/article_deploy/html/images/pharmaceutics-13-00516-ag.png)